Comparative exploration of the morphological plasticity of Trichodina centrostrigeata (Peritrichia: Mobilida), ectoparasite from the gills of two tilapia species (Oreochromis niloticus and O. mossambicus) in a global context

Trichodina centrostrigeata Basson, Van As et Paperna, 1983 from Oreochromis mossambicus (Peters) and O. niloticus (Linnaeus) from different host populations from Argentina, Mexico and South Africa was reviewed. Although T. centrostrigeata has a distinct denticle structure that makes morphological taxonomic inferences uncomplicated, variation of the denticles within and among individuals and populations were still observed. While traditional taxonomy of mobilines is heavily reliant on morphometrics, and recently even more so on molecular analysis, this paper proposes the use of geometric morphometry, specifically elliptical Fourier analysis, to address morphological conflicts that arise when comparing different populations. By applying this technique, combined with traditional taxonomy, it was found that T. centrostrigeata in this study can be grouped into two separate morphotypes, the first (type a) from aquaculture farms in Argentina and Mexico and the second (type b) from a natural habitat in Glen Alpine Dam, South Africa. This study supports the validity of geometric morphometry as an additional technique to distinguish not only between species but also evolutionary plasticity of the same species from different localities and habitats.Fil: Islas-Ortega, Alma Gabriela. Universidad Nacional Autónoma de México. Instituto de Biología; MéxicoFil: Marcotegui, Paula Soledad. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mar del Plata. Instituto de Investigaciones Marinas y Costeras. Universidad Nacional de Mar del Plata. Facultad de Ciencias Exactas y Naturales. Instituto de Investigaciones Marinas y Costeras; ArgentinaFil: Basson, Linda. University of the Free State; SudáfricaFil: de Jager, Gerhard P.. University of the Free State; SudáfricaFil: Aguilar Aguilar, Rogelio. Universidad Nacional Autónoma de México. Instituto de Biología; Méxic

Assessment policies and academic performance within a single course: The role of motivation and self-regulation.

Despite the frequently reported association of characteristics of assessment policies with academic performance, the mechanisms through which these policies affect performance are largely unknown. Therefore, the current research investigated performance, motivation and self-regulation for two groups of students following the same statistics course, but under two assessment policies: education and child studies (ECS) students studied under an assessment policy with relatively higher stakes, a higher performance standard and a lower resit standard, compared with Psychology students. Results show similar initial performance, but more use of resits and higher final performance (post-resit) under the ECS policy compared with the psychology policy. In terms of motivation and self-regulation, under the ECS policy significantly higher minimum grade goals, performance self-efficacy, task value, time and study environment management, and test anxiety were observed, but there were no significant differences in aimed grade goals, academic self-efficacy and effort regulation. The relations of motivational and selfregulatory factors with academic performance were similar between both assessment policies. Thus, educators should be keenly aware of how characteristics of assessment policies are related to students’ motivation, self-regulation and academic performance

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.

Importance: Evidence regarding corticosteroid use for severe coronavirus disease 2019 (COVID-19) is limited. Objective: To determine whether hydrocortisone improves outcome for patients with severe COVID-19. Design, Setting, and Participants: An ongoing adaptive platform trial testing multiple interventions within multiple therapeutic domains, for example, antiviral agents, corticosteroids, or immunoglobulin. Between March 9 and June 17, 2020, 614 adult patients with suspected or confirmed COVID-19 were enrolled and randomized within at least 1 domain following admission to an intensive care unit (ICU) for respiratory or cardiovascular organ support at 121 sites in 8 countries. Of these, 403 were randomized to open-label interventions within the corticosteroid domain. The domain was halted after results from another trial were released. Follow-up ended August 12, 2020. Interventions: The corticosteroid domain randomized participants to a fixed 7-day course of intravenous hydrocortisone (50 mg or 100 mg every 6 hours) (n = 143), a shock-dependent course (50 mg every 6 hours when shock was clinically evident) (n = 152), or no hydrocortisone (n = 108). Main Outcomes and Measures: The primary end point was organ support-free days (days alive and free of ICU-based respiratory or cardiovascular support) within 21 days, where patients who died were assigned -1 day. The primary analysis was a bayesian cumulative logistic model that included all patients enrolled with severe COVID-19, adjusting for age, sex, site, region, time, assignment to interventions within other domains, and domain and intervention eligibility. Superiority was defined as the posterior probability of an odds ratio greater than 1 (threshold for trial conclusion of superiority >99%). Results: After excluding 19 participants who withdrew consent, there were 384 patients (mean age, 60 years; 29% female) randomized to the fixed-dose (n = 137), shock-dependent (n = 146), and no (n = 101) hydrocortisone groups; 379 (99%) completed the study and were included in the analysis. The mean age for the 3 groups ranged between 59.5 and 60.4 years; most patients were male (range, 70.6%-71.5%); mean body mass index ranged between 29.7 and 30.9; and patients receiving mechanical ventilation ranged between 50.0% and 63.5%. For the fixed-dose, shock-dependent, and no hydrocortisone groups, respectively, the median organ support-free days were 0 (IQR, -1 to 15), 0 (IQR, -1 to 13), and 0 (-1 to 11) days (composed of 30%, 26%, and 33% mortality rates and 11.5, 9.5, and 6 median organ support-free days among survivors). The median adjusted odds ratio and bayesian probability of superiority were 1.43 (95% credible interval, 0.91-2.27) and 93% for fixed-dose hydrocortisone, respectively, and were 1.22 (95% credible interval, 0.76-1.94) and 80% for shock-dependent hydrocortisone compared with no hydrocortisone. Serious adverse events were reported in 4 (3%), 5 (3%), and 1 (1%) patients in the fixed-dose, shock-dependent, and no hydrocortisone groups, respectively. Conclusions and Relevance: Among patients with severe COVID-19, treatment with a 7-day fixed-dose course of hydrocortisone or shock-dependent dosing of hydrocortisone, compared with no hydrocortisone, resulted in 93% and 80% probabilities of superiority with regard to the odds of improvement in organ support-free days within 21 days. However, the trial was stopped early and no treatment strategy met prespecified criteria for statistical superiority, precluding definitive conclusions. Trial Registration: ClinicalTrials.gov Identifier: NCT02735707

Two euAGAMOUS genes control C-function in Medicago truncatula

[EN] C-function MADS-box transcription factors belong to the AGAMOUS (AG) lineage and specify both stamen and carpel identity and floral meristem determinacy. In core eudicots, the AG lineage is further divided into two branches, the euAG and PLE lineages. Functional analyses across flowering plants strongly support the idea that duplicated AG lineage genes have different degrees of subfunctionalization of the C-function. The legume Medicago truncatula contains three C-lineage genes in its genome: two euAG genes (MtAGa and MtAGb) and one PLENA-like gene (MtSHP). This species is therefore a good experimental system to study the effects of gene duplication within the AG subfamily. We have studied the respective functions of each euAG genes in M. truncatula employing expression analyses and reverse genetic approaches. Our results show that the M. truncatula euAG- and PLENA-like genes are an example of subfunctionalization as a result of a change in expression pattern. MtAGa and MtAGb are the only genes showing a full C-function activity, concomitant with their ancestral expression profile, early in the floral meristem, and in the third and fourth floral whorls during floral development. In contrast, MtSHP expression appears late during floral development suggesting it does not contribute significantly to the C-function. Furthermore, the redundant MtAGa and MtAGb paralogs have been retained which provides the overall dosage required to specify the C-function in M. truncatula.This work was funded by grants BIO2009-08134 and BIO2012-39849-C02-01 from the Spanish Ministry of Economy and Competitiveness and the Ramon y Cajal Program (RYC-2007-00627 to CGM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Serwatowska, J.; Roque Mesa, EM.; Gómez Mena, MC.; Constantin, GD.; Wen, J.; Mysore, KS.; Lund, OS.... (2014). Two euAGAMOUS genes control C-function in Medicago truncatula. PLoS ONE. 9(8):103770-1-103770-12. https://doi.org/10.1371/journal.pone.0103770S103770-1103770-1298Prunet, N., & Jack, T. P. (2013). Flower Development in Arabidopsis: There Is More to It Than Learning Your ABCs. Flower Development, 3-33. doi:10.1007/978-1-4614-9408-9_1Causier, B., Schwarz-Sommer, Z., & Davies, B. (2010). Floral organ identity: 20 years of ABCs. Seminars in Cell & Developmental Biology, 21(1), 73-79. doi:10.1016/j.semcdb.2009.10.005Irish, V. F. (2010). The flowering of Arabidopsis flower development. The Plant Journal, 61(6), 1014-1028. doi:10.1111/j.1365-313x.2009.04065.xHeijmans, K., Morel, P., & Vandenbussche, M. (2012). MADS-box Genes and Floral Development: the Dark Side. Journal of Experimental Botany, 63(15), 5397-5404. doi:10.1093/jxb/ers233Bowman, J. L., Smyth, D. R., & Meyerowitz, E. M. (1989). Genes directing flower development in Arabidopsis. The Plant Cell, 1(1), 37-52. doi:10.1105/tpc.1.1.37Yanofsky, M. F., Ma, H., Bowman, J. L., Drews, G. N., Feldmann, K. A., & Meyerowitz, E. M. (1990). The protein encoded by the Arabidopsis homeotic gene agamous resembles transcription factors. Nature, 346(6279), 35-39. doi:10.1038/346035a0Bradley, D., Carpenter, R., Sommer, H., Hartley, N., & Coen, E. (1993). Complementary floral homeotic phenotypes result from opposite orientations of a transposon at the plena locus of antirrhinum. Cell, 72(1), 85-95. doi:10.1016/0092-8674(93)90052-rPinyopich, A., Ditta, G. S., Savidge, B., Liljegren, S. J., Baumann, E., Wisman, E., & Yanofsky, M. F. (2003). Assessing the redundancy of MADS-box genes during carpel and ovule development. Nature, 424(6944), 85-88. doi:10.1038/nature01741Liljegren, S. J., Ditta, G. S., Eshed, Y., Savidge, B., Bowman, J. L., & Yanofsky, M. F. (2000). SHATTERPROOF MADS-box genes control seed dispersal in Arabidopsis. Nature, 404(6779), 766-770. doi:10.1038/35008089Davies, B., Motte, P., Keck, E., Saedler, H., Sommer, H., & Schwarz-Sommer, Z. (1999). PLENA and FARINELLI: redundancy and regulatory interactions between two Antirrhinum MADS-box factors controlling flower development. The EMBO Journal, 18(14), 4023-4034. doi:10.1093/emboj/18.14.4023Kramer, E. M., Jaramillo, M. A., & Di Stilio, V. S. (2004). Patterns of Gene Duplication and Functional Evolution During the Diversification of the AGAMOUS Subfamily of MADS Box Genes in Angiosperms. Genetics, 166(2), 1011-1023. doi:10.1534/genetics.166.2.1011Becker, A. (2003). The major clades of MADS-box genes and their role in the development and evolution of flowering plants. Molecular Phylogenetics and Evolution, 29(3), 464-489. doi:10.1016/s1055-7903(03)00207-0Irish, V. F. (2003). The evolution of floral homeotic gene function. BioEssays, 25(7), 637-646. doi:10.1002/bies.10292Zahn, L. M., Leebens-Mack, J. H., Arrington, J. M., Hu, Y., Landherr, L. L., dePamphilis, C. W., … Ma, H. (2006). Conservation and divergence in the AGAMOUS subfamily of MADS-box genes: evidence of independent sub- and neofunctionalization events. Evolution Development, 8(1), 30-45. doi:10.1111/j.1525-142x.2006.05073.xFerrandiz, C. (2000). Negative Regulation of the SHATTERPROOF Genes by FRUITFULL During Arabidopsis Fruit Development. Science, 289(5478), 436-438. doi:10.1126/science.289.5478.436Ma, H., Yanofsky, M. F., & Meyerowitz, E. M. (1991). AGL1-AGL6, an Arabidopsis gene family with similarity to floral homeotic and transcription factor genes. Genes & Development, 5(3), 484-495. doi:10.1101/gad.5.3.484Savidge, B., Rounsley, S. D., & Yanofsky, M. F. (1995). Temporal relationship between the transcription of two Arabidopsis MADS box genes and the floral organ identity genes. The Plant Cell, 7(6), 721-733. doi:10.1105/tpc.7.6.721Colombo, M., Brambilla, V., Marcheselli, R., Caporali, E., Kater, M. M., & Colombo, L. (2010). A new role for the SHATTERPROOF genes during Arabidopsis gynoecium development. Developmental Biology, 337(2), 294-302. doi:10.1016/j.ydbio.2009.10.043Fourquin, C., & Ferrándiz, C. (2012). Functional analyses of AGAMOUS family members in Nicotiana benthamiana clarify the evolution of early and late roles of C-function genes in eudicots. The Plant Journal, 71(6), 990-1001. doi:10.1111/j.1365-313x.2012.05046.xKapoor, M., Tsuda, S., Tanaka, Y., Mayama, T., Okuyama, Y., Tsuchimoto, S., & Takatsuji, H. (2002). Role of petuniapMADS3in determination of floral organ and meristem identity, as revealed by its loss of function. The Plant Journal, 32(1), 115-127. doi:10.1046/j.1365-313x.2002.01402.xPan, I. L., McQuinn, R., Giovannoni, J. J., & Irish, V. F. (2010). Functional diversification of AGAMOUS lineage genes in regulating tomato flower and fruit development. Journal of Experimental Botany, 61(6), 1795-1806. doi:10.1093/jxb/erq046Pnueli, L., Hareven, D., Rounsley, S. D., Yanofsky, M. F., & Lifschitz, E. (1994). Isolation of the tomato AGAMOUS gene TAG1 and analysis of its homeotic role in transgenic plants. The Plant Cell, 6(2), 163-173. doi:10.1105/tpc.6.2.163Dreni, L., & Kater, M. M. (2013). MADSreloaded: evolution of theAGAMOUSsubfamily genes. New Phytologist, 201(3), 717-732. doi:10.1111/nph.12555Brunner, A. M. (2000). Plant Molecular Biology, 44(5), 619-634. doi:10.1023/a:1026550205851Perl-Treves, R., Kahana, A., Rosenman, N., Xiang, Y., & Silberstein, L. (1998). Expression of Multiple AGAMOUS-Like Genes in Male and Female Flowers of Cucumber (Cucumis sativus L.). Plant and Cell Physiology, 39(7), 701-710. doi:10.1093/oxfordjournals.pcp.a029424Yu, D., Kotilainen, M., Pöllänen, E., Mehto, M., Elomaa, P., Helariutta, Y., … Teeri, T. H. (1999). Organ identity genes and modified patterns of flower development in Gerbera hybrida (Asteraceae). The Plant Journal, 17(1), 51-62. doi:10.1046/j.1365-313x.1999.00351.xDong, Z., Zhao, Z., Liu, C., Luo, J., Yang, J., Huang, W., … Luo, D. (2005). Floral Patterning in Lotus japonicus. Plant Physiology, 137(4), 1272-1282. doi:10.1104/pp.104.054288Hofer, J. M., & Noel Ellis, T. (2014). Developmental specialisations in the legume family. Current Opinion in Plant Biology, 17, 153-158. doi:10.1016/j.pbi.2013.11.014Fourquin, C., del Cerro, C., Victoria, F. C., Vialette-Guiraud, A., de Oliveira, A. C., & Ferrándiz, C. (2013). A Change in SHATTERPROOF Protein Lies at the Origin of a Fruit Morphological Novelty and a New Strategy for Seed Dispersal in Medicago Genus. Plant Physiology, 162(2), 907-917. doi:10.1104/pp.113.217570Hewitt EJ (1966) Sand and Water Culture Methods Used in the Study of Plant Nutrition. Farnham Royal, UK: Commonwealth Agricultural Bureau.Cheng, X., Wang, M., Lee, H.-K., Tadege, M., Ratet, P., Udvardi, M., … Wen, J. (2013). An efficient reverse genetics platform in the model legumeMedicago truncatula. New Phytologist, 201(3), 1065-1076. doi:10.1111/nph.12575D’ Erfurth, I., Cosson, V., Eschstruth, A., Lucas, H., Kondorosi, A., & Ratet, P. (2003). Efficient transposition of theTnt1tobacco retrotransposon in the model legumeMedicago truncatula. The Plant Journal, 34(1), 95-106. doi:10.1046/j.1365-313x.2003.01701.xTadege, M., Ratet, P., & Mysore, K. S. (2005). Insertional mutagenesis: a Swiss Army knife for functional genomics of Medicago truncatula. Trends in Plant Science, 10(5), 229-235. doi:10.1016/j.tplants.2005.03.009Tadege, M., Wen, J., He, J., Tu, H., Kwak, Y., Eschstruth, A., … Mysore, K. S. (2008). Large-scale insertional mutagenesis using the Tnt1 retrotransposon in the model legume Medicago truncatula. The Plant Journal, 54(2), 335-347. doi:10.1111/j.1365-313x.2008.03418.xCheng, X., Wen, J., Tadege, M., Ratet, P., & Mysore, K. S. (2010). Reverse Genetics in Medicago truncatula Using Tnt1 Insertion Mutants. Plant Reverse Genetics, 179-190. doi:10.1007/978-1-60761-682-5_13Benlloch, R., d’ Erfurth, I., Ferrandiz, C., Cosson, V., Beltrán, J. P., Cañas, L. A., … Ratet, P. (2006). Isolation of mtpim Proves Tnt1 a Useful Reverse Genetics Tool in Medicago truncatula and Uncovers New Aspects of AP1-Like Functions in Legumes. Plant Physiology, 142(3), 972-983. doi:10.1104/pp.106.083543Larkin, M. A., Blackshields, G., Brown, N. P., Chenna, R., McGettigan, P. A., McWilliam, H., … Higgins, D. G. (2007). Clustal W and Clustal X version 2.0. Bioinformatics, 23(21), 2947-2948. doi:10.1093/bioinformatics/btm404Altschul, S. (1997). Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Research, 25(17), 3389-3402. doi:10.1093/nar/25.17.3389Tamura, K., Dudley, J., Nei, M., & Kumar, S. (2007). MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0. Molecular Biology and Evolution, 24(8), 1596-1599. doi:10.1093/molbev/msm092Dellaporta, S. L., Wood, J., & Hicks, J. B. (1983). A plant DNA minipreparation: Version II. Plant Molecular Biology Reporter, 1(4), 19-21. doi:10.1007/bf02712670Schmittgen, T. D., & Livak, K. J. (2008). Analyzing real-time PCR data by the comparative CT method. Nature Protocols, 3(6), 1101-1108. doi:10.1038/nprot.2008.73Constantin, G. D., Krath, B. N., MacFarlane, S. A., Nicolaisen, M., Elisabeth Johansen, I., & Lund, O. S. (2004). Virus-induced gene silencing as a tool for functional genomics in a legume species. The Plant Journal, 40(4), 622-631. doi:10.1111/j.1365-313x.2004.02233.xWesley, S. V., Helliwell, C. A., Smith, N. A., Wang, M., Rouse, D. T., Liu, Q., … Waterhouse, P. M. (2001). Construct design for efficient, effective and high-throughput gene silencing in plants. The Plant Journal, 27(6), 581-590. doi:10.1046/j.1365-313x.2001.01105.xGuerineau F, Mullineaux P (1993) Plant transformation and expression vectors. In: Croy R, editor. Plant Molecular Biology. Oxford, UK: Bios Scientific Publishers, Academic Press. pp. 121–147.Clough, S. J., & Bent, A. F. (1998). Floral dip: a simplified method forAgrobacterium-mediated transformation ofArabidopsis thaliana. The Plant Journal, 16(6), 735-743. doi:10.1046/j.1365-313x.1998.00343.xBenlloch, R., Roque, E., Ferrándiz, C., Cosson, V., Caballero, T., Penmetsa, R. V., … Madueño, F. (2009). Analysis of B function in legumes: PISTILLATA proteins do not require the PI motif for floral organ development inMedicago truncatula. The Plant Journal, 60(1), 102-111. doi:10.1111/j.1365-313x.2009.03939.xRoque, E., Serwatowska, J., Cruz Rochina, M., Wen, J., Mysore, K. S., Yenush, L., … Cañas, L. A. (2012). Functional specialization of duplicated AP3-like genes inMedicago truncatula. The Plant Journal, 73(4), 663-675. doi:10.1111/tpj.12068Flanagan, C. A., Hu, Y., & Ma, H. (1996). Specific expression of the AGL1 MADS-box gene suggests regulatory functions in Arabidopsis gynoecium and ovule development. The Plant Journal, 10(2), 343-353. doi:10.1046/j.1365-313x.1996.10020343.xSieburth, L. E., & Meyerowitz, E. M. (1997). Molecular dissection of the AGAMOUS control region shows that cis elements for spatial regulation are located intragenically. The Plant Cell, 9(3), 355-365. doi:10.1105/tpc.9.3.355Busch, M. A. (1999). Activation of a Floral Homeotic Gene in Arabidopsis. Science, 285(5427), 585-587. doi:10.1126/science.285.5427.585Moyroud, E., Minguet, E. G., Ott, F., Yant, L., Posé, D., Monniaux, M., … Parcy, F. (2011). Prediction of Regulatory Interactions from Genome Sequences Using a Biophysical Model for the Arabidopsis LEAFY Transcription Factor. The Plant Cell, 23(4), 1293-1306. doi:10.1105/tpc.111.083329Grønlund, M., Constantin, G., Piednoir, E., Kovacev, J., Johansen, I. E., & Lund, O. S. (2008). Virus-induced gene silencing in Medicago truncatula and Lathyrus odorata. Virus Research, 135(2), 345-349. doi:10.1016/j.virusres.2008.04.005Mandel, M. A., Bowman, J. L., Kempin, S. A., Ma, H., Meyerowitz, E. M., & Yanofsky, M. F. (1992). Manipulation of flower structure in transgenic tobacco. Cell, 71(1), 133-143. doi:10.1016/0092-8674(92)90272-eMizukami, Y., & Ma, H. (1992). Ectopic expression of the floral homeotic gene AGAMOUS in transgenic Arabidopsis plants alters floral organ identity. Cell, 71(1), 119-131. doi:10.1016/0092-8674(92)90271-dCannon, S. B., Sterck, L., Rombauts, S., Sato, S., Cheung, F., Gouzy, J., … Young, N. D. (2006). Legume genome evolution viewed through the Medicago truncatula and Lotus japonicus genomes. Proceedings of the National Academy of Sciences, 103(40), 14959-14964. doi:10.1073/pnas.0603228103Young, N. D., & Bharti, A. K. (2012). Genome-Enabled Insights into Legume Biology. Annual Review of Plant Biology, 63(1), 283-305. doi:10.1146/annurev-arplant-042110-103754Jager, M. (2003). MADS-Box Genes in Ginkgo biloba and the Evolution of the AGAMOUS Family. Molecular Biology and Evolution, 20(5), 842-854. doi:10.1093/molbev/msg089Johansen, B., Pedersen, L. B., Skipper, M., & Frederiksen, S. (2002). MADS-box gene evolution—structure and transcription patterns. Molecular Phylogenetics and Evolution, 23(3), 458-480. doi:10.1016/s1055-7903(02)00032-5Rutledge, R., Regan, S., Nicolas, O., Fobert, P., Côté, C., Bosnich, W., … Stewart, D. (1998). Characterization of an AGAMOUS homologue from the conifer black spruce ( Picea mariana ) that produces floral homeotic conversions when expressed in Arabidopsis. The Plant Journal, 15(5), 625-634. doi:10.1046/j.1365-313x.1998.00250.xParcy, F., Nilsson, O., Busch, M. A., Lee, I., & Weigel, D. (1998). A genetic framework for floral patterning. Nature, 395(6702), 561-566. doi:10.1038/26903Causier, B., Bradley, D., Cook, H., & Davies, B. (2009). Conserved intragenic elements were critical for the evolution of the floral C-function. The Plant Journal, 58(1), 41-52. doi:10.1111/j.1365-313x.2008.03759.xAiroldi, C. A., & Davies, B. (2012). Gene Duplication and the Evolution of Plant MADS-box Transcription Factors. Journal of Genetics and Genomics, 39(4), 157-165. doi:10.1016/j.jgg.2012.02.008Giménez, E., Pineda, B., Capel, J., Antón, M. T., Atarés, A., Pérez-Martín, F., … Lozano, R. (2010). Functional Analysis of the Arlequin Mutant Corroborates the Essential Role of the ARLEQUIN/TAGL1 Gene during Reproductive Development of Tomato. PLoS ONE, 5(12), e14427. doi:10.1371/journal.pone.0014427Kater, M. M., Colombo, L., Franken, J., Busscher, M., Masiero, S., Van Lookeren Campagne, M. M., & Angenent, G. C. (1998). Multiple AGAMOUS Homologs from Cucumber and Petunia Differ in Their Ability to Induce Reproductive Organ Fate. The Plant Cell, 10(2), 171-182. doi:10.1105/tpc.10.2.171Tsuchimoto, S., van der Krol, A. R., & Chua, N. H. (1993). Ectopic expression of pMADS3 in transgenic petunia phenocopies the petunia blind mutant. The Plant Cell, 5(8), 843-853. doi:10.1105/tpc.5.8.843Airoldi, C. A., Bergonzi, S., & Davies, B. (2010). Single amino acid change alters the ability to specify male or female organ identity. Proceedings of the National Academy of Sciences, 107(44), 18898-18902. doi:10.1073/pnas.1009050107Causier, B., Castillo, R., Zhou, J., Ingram, R., Xue, Y., Schwarz-Sommer, Z., & Davies, B. (2005). Evolution in Action: Following Function in Duplicated Floral Homeotic Genes. Current Biology, 15(16), 1508-1512. doi:10.1016/j.cub.2005.07.063Birchler, J. A., & Veitia, R. A. (2007). The Gene Balance Hypothesis: From Classical Genetics to Modern Genomics. The Plant Cell, 19(2), 395-402. doi:10.1105/tpc.106.049338Birchler, J. A., & Veitia, R. A. (2009). The gene balance hypothesis: implications for gene regulation, quantitative traits and evolution. New Phytologist, 186(1), 54-62. doi:10.1111/j.1469-8137.2009.03087.xEdger, P. P., & Pires, J. C. (2009). Gene and genome duplications: the impact of dosage-sensitivity on the fate of nuclear genes. Chromosome Research, 17(5), 699-717. doi:10.1007/s10577-009-9055-9Freeling, M. (2006). Gene-balanced duplications, like tetraploidy, provide predictable drive to increase morphological complexity. Genome Research, 16(7), 805-814. doi:10.1101/gr.368140

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

BACKGROUND: A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four trials. METHODS: This analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Africa. Participants aged 18 years and older were randomly assigned (1:1) to ChAdOx1 nCoV-19 vaccine or control (meningococcal group A, C, W, and Y conjugate vaccine or saline). Participants in the ChAdOx1 nCoV-19 group received two doses containing 5 × 1010 viral particles (standard dose; SD/SD cohort); a subset in the UK trial received a half dose as their first dose (low dose) and a standard dose as their second dose (LD/SD cohort). The primary efficacy analysis included symptomatic COVID-19 in seronegative participants with a nucleic acid amplification test-positive swab more than 14 days after a second dose of vaccine. Participants were analysed according to treatment received, with data cutoff on Nov 4, 2020. Vaccine efficacy was calculated as 1 - relative risk derived from a robust Poisson regression model adjusted for age. Studies are registered at ISRCTN89951424 and ClinicalTrials.gov, NCT04324606, NCT04400838, and NCT04444674. FINDINGS: Between April 23 and Nov 4, 2020, 23 848 participants were enrolled and 11 636 participants (7548 in the UK, 4088 in Brazil) were included in the interim primary efficacy analysis. In participants who received two standard doses, vaccine efficacy was 62·1% (95% CI 41·0-75·7; 27 [0·6%] of 4440 in the ChAdOx1 nCoV-19 group vs71 [1·6%] of 4455 in the control group) and in participants who received a low dose followed by a standard dose, efficacy was 90·0% (67·4-97·0; three [0·2%] of 1367 vs 30 [2·2%] of 1374; pinteraction=0·010). Overall vaccine efficacy across both groups was 70·4% (95·8% CI 54·8-80·6; 30 [0·5%] of 5807 vs 101 [1·7%] of 5829). From 21 days after the first dose, there were ten cases hospitalised for COVID-19, all in the control arm; two were classified as severe COVID-19, including one death. There were 74 341 person-months of safety follow-up (median 3·4 months, IQR 1·3-4·8): 175 severe adverse events occurred in 168 participants, 84 events in the ChAdOx1 nCoV-19 group and 91 in the control group. Three events were classified as possibly related to a vaccine: one in the ChAdOx1 nCoV-19 group, one in the control group, and one in a participant who remains masked to group allocation. INTERPRETATION: ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic COVID-19 in this interim analysis of ongoing clinical trials. FUNDING: UK Research and Innovation, National Institutes for Health Research (NIHR), Coalition for Epidemic Preparedness Innovations, Bill & Melinda Gates Foundation, Lemann Foundation, Rede D'Or, Brava and Telles Foundation, NIHR Oxford Biomedical Research Centre, Thames Valley and South Midland's NIHR Clinical Research Network, and AstraZeneca

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Background A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four trials. Methods This analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Africa. Participants aged 18 years and older were randomly assigned (1:1) to ChAdOx1 nCoV-19 vaccine or control (meningococcal group A, C, W, and Y conjugate vaccine or saline). Participants in the ChAdOx1 nCoV-19 group received two doses containing 5 × 1010 viral particles (standard dose; SD/SD cohort); a subset in the UK trial received a half dose as their first dose (low dose) and a standard dose as their second dose (LD/SD cohort). The primary efficacy analysis included symptomatic COVID-19 in seronegative participants with a nucleic acid amplification test-positive swab more than 14 days after a second dose of vaccine. Participants were analysed according to treatment received, with data cutoff on Nov 4, 2020. Vaccine efficacy was calculated as 1 - relative risk derived from a robust Poisson regression model adjusted for age. Studies are registered at ISRCTN89951424 and ClinicalTrials.gov, NCT04324606, NCT04400838, and NCT04444674. Findings Between April 23 and Nov 4, 2020, 23 848 participants were enrolled and 11 636 participants (7548 in the UK, 4088 in Brazil) were included in the interim primary efficacy analysis. In participants who received two standard doses, vaccine efficacy was 62·1% (95% CI 41·0–75·7; 27 [0·6%] of 4440 in the ChAdOx1 nCoV-19 group vs71 [1·6%] of 4455 in the control group) and in participants who received a low dose followed by a standard dose, efficacy was 90·0% (67·4–97·0; three [0·2%] of 1367 vs 30 [2·2%] of 1374; pinteraction=0·010). Overall vaccine efficacy across both groups was 70·4% (95·8% CI 54·8–80·6; 30 [0·5%] of 5807 vs 101 [1·7%] of 5829). From 21 days after the first dose, there were ten cases hospitalised for COVID-19, all in the control arm; two were classified as severe COVID-19, including one death. There were 74 341 person-months of safety follow-up (median 3·4 months, IQR 1·3–4·8): 175 severe adverse events occurred in 168 participants, 84 events in the ChAdOx1 nCoV-19 group and 91 in the control group. Three events were classified as possibly related to a vaccine: one in the ChAdOx1 nCoV-19 group, one in the control group, and one in a participant who remains masked to group allocation. Interpretation ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic COVID-19 in this interim analysis of ongoing clinical trials

Freely Available Training Videos for Suicide Prevention: Scoping Review

BackgroundFreely available and asynchronous implementation supports can reduce the resource burden of evidence-based practice training to facilitate uptake. Freely available web-based training videos have proliferated, yet there have been no efforts to quantify their breadth, depth, and content for suicide prevention. ObjectiveThis study presents results from a scoping review of freely available training videos for suicide prevention and describes a methodological framework for reviewing such videos. MethodsA scoping review of freely available training videos (≥2 minutes) for suicide prevention practices was conducted using 4 large video-sharing platforms: YouTube, Vimeo, Bing Video, and Google Video. Identified suicide prevention training videos (N=506) were reviewed and coded. ResultsMost content was targeted toward gatekeepers or other lay providers (n=370) versus clinical providers (n=136). Videos most commonly provided content related to suicidal thoughts or behaviors (n=420). Many videos (n=274, 54.2%) included content designed for certain communities or organizations. Less than half (n=232, 45.8%) of training videos included formal clinical content pertaining to assessment or intervention for suicide prevention. ConclusionsResults suggested an abundance of videos providing broad informational content (eg, “signs and symptoms of someone at risk for suicide”) and a limited portion of videos with instructional content aimed at clinical providers delivering formal evidence-based assessments or interventions for suicide prevention. Development of resources to address identified gaps may be needed. Future work may leverage machine learning techniques to expedite the review process

Future perspective for the application of predictive biomarker testing in advanced stage non-small cell lung cancer

For patients with advanced stage non-small cell lung cancer (NSCLC), treatment strategies have changed significantly due to the introduction of targeted therapies and immunotherapy. In the last few years, we have seen an explosive growth of newly introduced targeted therapies in oncology and this development is expected to continue in the future. Besides primary targetable aberrations, emerging diagnostic biomarkers also include relevant co-occurring mutations and resistance mechanisms involved in disease progression, that have impact on optimal treatment management. To accommodate testing of pending biomarkers, it is necessary to establish routine large-panel next-generation sequencing (NGS) for all patients with advanced stage NSCLC. For cost-effectiveness and accessibility, it is recommended to implement predictive molecular testing using large-panel NGS in a dedicated, centralized expert laboratory within a regional oncology network. The central molecular testing center should host a regional Molecular Tumor Board and function as a hub for interpretation of rare and complex testing results and clinical decision-making.</p